Application

CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT.

Aurinia Pharmaceuticals Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88907266
Filing Date: 05/08/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88907266
MARK INFORMATION
*MARK CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT.
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT.
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Aurinia Pharmaceuticals Inc.
*MAILING ADDRESS 1203-4464 Markham Street
*CITY Victoria, BC
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
V8Z7X8
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY UNDER WHICH ORGANIZED Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 042 
*IDENTIFICATION Research and development of medicinals and pharmaceuticals
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 2024836
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
       FOREIGN FILING DATE 04/27/2020
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical information services, namely, providing health and medical information in the field of diagnostic and treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis; conducting medical studies in the field of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis; medical evaluation services, namely conducting patients studies and functional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and assessment program effectiveness
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 2024836
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
       FOREIGN FILING DATE 04/27/2020
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Matthew R. Wilmot
ATTORNEY DOCKET NUMBER 66570-15
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Stoel Rives LLP
STREET 760 SW Ninth Avenue, Suite 3000
CITY Portland
STATE Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 97205
PHONE 503-294-9851
FAX 503-220-2480
EMAIL ADDRESS TM-PDX@STOEL.COM
OTHER APPOINTED ATTORNEY Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Catherine P. Lake, Joshua G. Gigger
CORRESPONDENCE INFORMATION
NAME Matthew R. Wilmot
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE TM-PDX@STOEL.COM
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 550
*TOTAL FEES PAID 550
SIGNATURE INFORMATION
SIGNATURE /Erik Eglite/
SIGNATORY'S NAME Dr. Erik Eglite
SIGNATORY'S POSITION Senior Vice President, General Counsel
SIGNATORY'S PHONE NUMBER 503-294-9851
DATE SIGNED 05/07/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88907266
Filing Date: 05/08/020

To the Commissioner for Trademarks:

MARK: CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT. (Standard Characters, see mark)
The literal element of the mark consists of CHANGING THE COURSE OF AUTOIMMUNE DISEASE INSPIRED BY PATIENTS. DRIVEN TO MAKE AN IMPACT.. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Aurinia Pharmaceuticals Inc., a company organized under the laws of Canada, having an address of
      1203-4464 Markham Street
      Victoria, BC V8Z7X8
      Canada
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 042:  Research and development of medicinals and pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2024836, filed 04/27/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 044:  Medical information services, namely, providing health and medical information in the field of diagnostic and treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis; conducting medical studies in the field of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis; medical evaluation services, namely conducting patients studies and functional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and assessment program effectiveness
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2024836, filed 04/27/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Matthew R. Wilmot. Other appointed attorneys are Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Catherine P. Lake, Joshua G. Gigger. Matthew R. Wilmot of Stoel Rives LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      760 SW Ninth Avenue, Suite 3000
      Portland, Oregon 97205
      United States
      503-294-9851(phone)
      503-220-2480(fax)
      TM-PDX@STOEL.COM
The docket/reference number is 66570-15.
Matthew R. Wilmot submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Matthew R. Wilmot
       PRIMARY EMAIL FOR CORRESPONDENCE: TM-PDX@STOEL.COM       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Erik Eglite/   Date: 05/07/2020
Signatory's Name: Dr. Erik Eglite
Signatory's Position: Senior Vice President, General Counsel
Payment Sale Number: 88907266
Payment Accounting Date: 05/08/2020

Serial Number: 88907266
Internet Transmission Date: Fri May 08 15:26:44 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202005081526441
94525-88907266-7104fd660c45f6d4e198eda74
39b681aefafaca7f4c791228f36635a94996c8a8
94-CC-26421197-20200506203436455071

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed